Useful Resources
What are Advanced Therapies Medicinal Products (ATMPs)?
-
Advanced Therapy Medicinal Products: Overview
-
Briefing Session
Gene Therapies: Transforming the lives of patients today – Bakhuti Shengelia (Novartis)
-
Briefing Session
The value of cell and gene therapies for patients and healthcare systems – Avril Daly (Retina International)
-
Briefing Session
Understanding the promise of cell and gene therapies – Prof. Francesco Muntoni (UCL)
The Lifecycle of ATMPs: from Early Diagnosis to Access to Patients
- How can we maximise the value of cell and gene therapies through early detection?
-
Briefing Session
Introductions by MEP Pietikäinen & MEP Kympouropoulos
Read more ↓Speakers:
MEP Sirpa Pietikainen (EPP, FI)
MEP Stelios Kympouropoulos (EPP, GR)
Victor Maertens, Government Affairs Manager, EUCOPE
- How to make Europe more attractive for cell and gene therapy development?
-
Briefing Session
Introductions by MEP Pernille Weiss (EPP, DK), MEP Radka Maxova (S&D, CZ) and Victor Maertens (EUCOPE)
Read more ↓Module 6: How to make Europe more attractive for gene and cell therapy development?
- MEP Pernille Weiss (EPP, DK)
- MEP Radka Maxova (S&D, CZ)
- Victor Maertens (Government Affairs Manager, EUCOPE)
- How are cell and gene therapies manufactured?
-
Gene Therapy Manufacturing – PTC Centre of Excellence
- Gene & cell therapy regulation and what it means for the revision of the pharmaceutical legislation?
-
Briefing Session
Martina Schussler-Lenz (EMA Committee for Advanced Therapies, Paul-Ehrlich Institute)
- Towards better use and exchange of Real-World Evidence for cell and gene therapies
-
Briefing Session
Introduction by MEP Susana Solis, MEP Manuel Pizarro & Victor Maertens (EUCOPE)
Literature
-
Event Report
INAMI (2019), Innovative funding solutions for paradigm changing advanced therapy medicinal products (ATMP) in Belgium
-
Academic Article
van Overbeeke et al (2020), Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions
-
Academic Article
Reineke et al (2022), Market access to new anticancer medicines for children and adolescents with cancer in Europe
-
Academic Article
Gene therapy in the putamen for curing AADC deficiency and Parkinson’s disease
European Gene and Cell Therapy Database
-
European Gene and Cell Therapy Database